Proteinuria as the cause of early dose modification in Japanese patients with metastatic colorectal cancer treated with fruquintinib: a multicenter real-world study - Shohei Udagawa; Chihiro Ishizuka; Hiroki Osumi; Toshiharu Hirose; Natsuko Okita; Hidekazu Hirano; Hirokazu Shoji; Ken Kato; Koichiro Yoshino; Keitaro Shimozaki; Shota Fukuoka; Takeru Wakatsuki; et al. (International Journal of Clinical Oncology, 2026)